- Home
- EXEEL vs BIO Comparison
EXEEL vs BIO Comparison
Compare EXEEL & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEEL
- BIO
- Stock Information
- Founded
- EXEEL N/A
- BIO 1952
- Country
- EXEEL United States
- BIO United States
- Employees
- EXEEL N/A
- BIO N/A
- Industry
- EXEEL Oil & Gas Production
- BIO Biotechnology: Laboratory Analytical Instruments
- Sector
- EXEEL Energy
- BIO Industrials
- Exchange
- EXEEL Nasdaq
- BIO Nasdaq
- Market Cap
- EXEEL 8.2B
- BIO 9.5B
- IPO Year
- EXEEL N/A
- BIO N/A
- Fundamental
- Price
- EXEEL $71.34
- BIO $343.99
- Analyst Decision
- EXEEL
- BIO Strong Buy
- Analyst Count
- EXEEL 0
- BIO 4
- Target Price
- EXEEL N/A
- BIO $381.50
- AVG Volume (30 Days)
- EXEEL N/A
- BIO 468.5K
- Earning Date
- EXEEL N/A
- BIO 10-30-2024
- Dividend Yield
- EXEEL N/A
- BIO N/A
- EPS Growth
- EXEEL N/A
- BIO N/A
- EPS
- EXEEL N/A
- BIO N/A
- Revenue
- EXEEL N/A
- BIO $2,562,604,000.00
- Revenue This Year
- EXEEL N/A
- BIO N/A
- Revenue Next Year
- EXEEL N/A
- BIO $4.49
- P/E Ratio
- EXEEL N/A
- BIO N/A
- Revenue Growth
- EXEEL N/A
- BIO N/A
- 52 Week Low
- EXEEL N/A
- BIO $261.59
- 52 Week High
- EXEEL N/A
- BIO $364.24
- Technical
- Relative Strength Index (RSI)
- EXEEL N/A
- BIO 56.50
- Support Level
- EXEEL N/A
- BIO $329.08
- Resistance Level
- EXEEL N/A
- BIO $346.09
- Average True Range (ATR)
- EXEEL 0.00
- BIO 8.23
- MACD
- EXEEL 0.00
- BIO -0.23
- Stochastic Oscillator
- EXEEL 0.00
- BIO 70.12
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.